SINTX TECHNOLOGIES INC (SINT)
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-09
$1.82+4.60%
Close 2026-09-09 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-09
Broken: Primary pillar broken — Reduce operating losses from -$3.2 million: metric not reported.
Sintx Technologies raised $4.5 million in a private placement to improve its finances. The company is working to meet Nasdaq listing rules. If it reduces operating losses from the current -$3.2 million level, it can stabilize. The recent M&A activity may help growth.
Sintx is losing money and revenue is expected to fall about 46% next year. The company faces Nasdaq delisting risk and worsening operating losses. The stock price is high compared to its weak outlook. Capital raises dilute shareholders and may not fix problems.
The stock price is about 41% above our valuation model and analysts expect revenue to drop about 46% next year. The market seems too optimistic given the company's losses and regulatory risks.
Breaks if: Fails to regain Nasdaq compliance by FY26
Breaks if: Operating losses worsen or remain below -$3 million by FY27
Fails to raise $4.5 million by 2026 Q2
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a speculative growth opportunity. The company is currently loss-making and has shown volatile management performance, which adds to the uncertainty in its long-term outlook.
The market appears to be pricing in a stretched valuation compared to peers, with a durable premium. There is a modest expectations gap, suggesting that investors may have some optimism about future performance despite current challenges.
Fundamentals may remain under pressure in the near term due to a high probability of an earnings miss. Recent financial performance has been neutral, but the company is working on advancing its commercialization efforts, which could provide some growth.
The thesis hinges on the company's ability to manage its guidance effectively and capitalize on favorable sector trends. Key factors include the performance of larger healthcare companies and the overall economic environment, particularly job growth.
The most important moves since the prior daily snapshot.
Mixed, the news cuts both ways. Revenue growth is strong, improving financial performance. However, shares slipped after the earnings call, raising market concerns.
as of 2026-09-09
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
In the next 1 to 3 years, SINT's trajectory will depend on its execution against strategic priorities and external market conditions. Not investment advice.